Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Enrofloxacin chewable tablets for dog or cat

A technology of enrofloxacin and chewable tablets, applied in the field of chewable tablets, can solve problems such as poor palatability, reduce waste and improve the cure rate.

Inactive Publication Date: 2008-06-04
TIANJIN RINGPU BIO TECH
View PDF0 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] Aiming at the physiological characteristics of dogs and cats, the inventor broke through the shortcomings of poor palatability of existing tablets, and developed a chewable tablet suitable for dogs and cats, which can be fully chewed and absorbed, effectively improving the utilization rate of therapeutic drugs , Guaranteed the dosage and improved the cure rate of dog and cat diseases

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0018] Example 1: Enrofloxacin Chewable Tablets

[0019] Take 2400g of starch and bake at 100°C for 1 hour, cool to room temperature; take another 300g of enrofloxacin and 60g of aspartame, dilute and mix with the cooled starch by equal amount incremental dilution method, pass through 60 meshes, and finish Mixture A was obtained by sieving three times. Put mixture A, 600 g of oral glucose, 600 g of skimmed milk powder and 2040 g of starch into a mixer and mix evenly to obtain mixture B, which is set aside. After mixing glycerin and absolute ethanol in a ratio of 1:10, 2.5 L was taken, and 200 g of polyvinylpyrrolidone was added thereto to prepare a polyvinylpyrrolidone glycerol-ethanol mixed solution.

[0020] Add the polyvinylpyrrolidone glycerol-ethanol mixed solution to the mixture B under stirring, until all the addition is complete, and a soft material with uniform mixing and moderate humidity is obtained. Granulate with a 16-mesh sieve and ventilate and dry at 50°C. A...

Embodiment 2

[0028] Example 2: Enrofloxacin Chewable Tablets

[0029] Get starch 1170g, enrofloxacin 960g, aspartame 210g and prepare mixture A by the method described in Example 1.

[0030] Put mixture A, 375g of oral glucose, 1125g of skimmed milk powder and 2430g of starch into a mixer and mix evenly to obtain mixture B, which is set aside. Mix glycerin and absolute ethanol uniformly at a ratio of 1:5, take 2.5 L, add 200 g of polyvinylpyrrolidone to it to make a polyvinylpyrrolidone glycerol-ethanol mixed solution as a binder.

[0031] Add the polyvinylpyrrolidone glycerol-ethanol mixed solution to the mixture B under stirring, until all the addition is complete, and a soft material with uniform mixing and moderate humidity is obtained. Accurately weigh 30 g of magnesium stearate for granulation, granulate, dry, granulate, and compress according to the method described in Example 1. A total of about 10,000 tablets were produced, each weighing 0.6g, containing 0.096g of enrofloxacin. ...

Embodiment 3

[0032] Example 3: Enrofloxacin Chewable Tablets

[0033] Get 1500g of starch, 1200g of enrofloxacin, and 300g of aspartame, and prepare mixture A according to the method described in Example 1. Put mixture A, 360 g of oral glucose, 1440 g of skim milk powder and 2100 g of starch into a mixer and mix evenly to obtain mixture B, which is set aside. Mix glycerin and absolute ethanol uniformly at a ratio of 1:10, take 2.5 L, add polyvinylpyrrolidone 200 g to it to make a polyvinylpyrrolidone glycerol-ethanol mixed solution as a binder.

[0034] Add the polyvinylpyrrolidone glycerol-ethanol mixed solution to the mixture B under stirring, until all the addition is complete, and a soft material with uniform mixing and moderate humidity is obtained. Accurately weigh 30 g of magnesium stearate for granulation, granulate, dry, granulate, and compress according to the method described in Example 1. A total of about 10,000 tablets were produced, each weighing 0.6g, containing 0.18g of e...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses an enrofloxacin chewable tablet used for dogs and cats. The invention overcomes the poor palatability defect of the existing tablet to promote the thorough chewing absorption by dogs and cats, so as to effectively guarantee the medicine-supply dose, to enhance the cure rate of diseases of dogs and cats and to reduce the medicine waste. The tablet of the invention comprises the following components represented by weight-percentage: 1 to 5 percent of aspartame; 20 to 30 percent of a mixture of oral dextrose and degreased milk powder, and the ratio of 1:1 to 1:4 between the oral dextrose and degreased milk powder in the mixture; 40 to 60 percent of excipient; 0.5 to 1 percent of glidant and 5 to 20 percent of enrofloxacin.

Description

technical field [0001] The invention relates to the preparation technology of veterinary medicine, in particular to a chewable tablet with good palatability for dogs and cats. Background technique [0002] Pet breeding has a long history in our country. With the improvement of living standards, the number of expensive dogs and cats is gradually increasing, and pet owners are paying more and more attention to the quality of life of their pets. Dogs and cats are mammals, and they also have their own common diseases. At present, the treatment of dog and cat diseases is mainly based on intravenous drip and intramuscular injection. Interruption of treatment often results in a poor prognosis of the disease. If dogs and cats can be made to actively take therapeutic drugs orally, this series of problems will be solved, but the few veterinary tablets currently on the market are often difficult to popularize because of their poor palatability. Contents of the invention [0003] A...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K9/20A61K31/496A61P31/04
Inventor 李旭东鲍恩东苏建东
Owner TIANJIN RINGPU BIO TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com